JP2017526614A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526614A5
JP2017526614A5 JP2016563838A JP2016563838A JP2017526614A5 JP 2017526614 A5 JP2017526614 A5 JP 2017526614A5 JP 2016563838 A JP2016563838 A JP 2016563838A JP 2016563838 A JP2016563838 A JP 2016563838A JP 2017526614 A5 JP2017526614 A5 JP 2017526614A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
cycloalkyl
aryl
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016563838A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017526614A (ja
JP6592008B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/026811 external-priority patent/WO2015175171A1/en
Publication of JP2017526614A publication Critical patent/JP2017526614A/ja
Publication of JP2017526614A5 publication Critical patent/JP2017526614A5/ja
Application granted granted Critical
Publication of JP6592008B2 publication Critical patent/JP6592008B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016563838A 2014-04-23 2015-04-21 オートタキシンの置換n−(2−アミノ)−2−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにlpa依存性またはlpa媒介性疾患の処置における使用 Expired - Fee Related JP6592008B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461983146P 2014-04-23 2014-04-23
US61/983,146 2014-04-23
PCT/US2015/026811 WO2015175171A1 (en) 2014-04-23 2015-04-21 Substituted n-(2-(amino)-2-oxoethyl)benzamide inhibitors of autotaxin and their preparation and use in the treatment of lpa-dependent or lpa-mediated diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019170253A Division JP2020007360A (ja) 2014-04-23 2019-09-19 オートタキシンの置換n−(2−アミノ)−2−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにlpa依存性またはlpa媒介性疾患の処置における使用

Publications (3)

Publication Number Publication Date
JP2017526614A JP2017526614A (ja) 2017-09-14
JP2017526614A5 true JP2017526614A5 (enExample) 2018-05-24
JP6592008B2 JP6592008B2 (ja) 2019-10-16

Family

ID=54480420

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016563838A Expired - Fee Related JP6592008B2 (ja) 2014-04-23 2015-04-21 オートタキシンの置換n−(2−アミノ)−2−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにlpa依存性またはlpa媒介性疾患の処置における使用
JP2019170253A Pending JP2020007360A (ja) 2014-04-23 2019-09-19 オートタキシンの置換n−(2−アミノ)−2−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにlpa依存性またはlpa媒介性疾患の処置における使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019170253A Pending JP2020007360A (ja) 2014-04-23 2019-09-19 オートタキシンの置換n−(2−アミノ)−2−オキソエチルベンズアミド阻害剤およびそれらの調製、ならびにlpa依存性またはlpa媒介性疾患の処置における使用

Country Status (6)

Country Link
US (1) US20170037007A1 (enExample)
EP (1) EP3134079A4 (enExample)
JP (2) JP6592008B2 (enExample)
CN (1) CN107205972A (enExample)
BR (1) BR112016024473A2 (enExample)
WO (1) WO2015175171A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015154023A1 (en) 2014-04-04 2015-10-08 X-Rx Discovery, Inc. Substituted spirocydic inhibitors of autotaxin
JP6860551B2 (ja) 2016-03-11 2021-04-14 武田薬品工業株式会社 芳香環化合物
TWI885539B (zh) 2017-09-29 2025-06-01 日商第一三共股份有限公司 抗體-吡咯并苯二氮呯衍生物複合體
CN108753699B (zh) * 2018-06-19 2021-04-30 青岛农业大学 一种玉米赤霉烯酮对猪卵母细胞体外发育危害的挽救方法
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
AU2020246448A1 (en) * 2019-03-25 2021-10-14 Daiichi Sankyo Company, Limited Anti-HER2 antibody-pyrrolobenzodiazepine derivative conjugate
WO2021122645A1 (en) 2019-12-20 2021-06-24 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
US12383547B2 (en) 2020-07-01 2025-08-12 Vanderbilt University Methods of treatment for a kidney disease
CN113943274B (zh) * 2020-07-16 2025-07-15 武汉人福创新药物研发中心有限公司 酰胺类化合物及其制备方法
CN112675308B (zh) * 2020-12-09 2023-05-05 中国人民解放军军事科学院军事医学研究院 抑制enpp2基因和/或蛋白表达的物质在制备治疗多发性骨髓瘤的药物中的应用
EP4599849A3 (en) 2021-01-05 2025-10-22 Zydus Lifesciences Limited Novel inhibitors of autotaxin
KR102524669B1 (ko) * 2021-10-01 2023-04-21 주식회사 넥스트젠바이오사이언스 신규한 피페리딘 유도체 및 이를 포함하는 오토탁신 저해용 약학 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056729A1 (en) * 1999-03-24 2000-09-28 Anormed Inc. Chemokine recpetor binding heterocyclic compounds
GB0030303D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
JP2004529184A (ja) * 2001-05-10 2004-09-24 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規1−アミドメチルカルボニル−ピペリジン誘導体、該誘導体を製造するための方法及び中間体並びにこれらの化合物を含有している医薬
EP1597256A1 (en) * 2003-02-21 2005-11-23 Pfizer Inc. N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
EP1599447A1 (en) * 2003-02-28 2005-11-30 Galderma Research & Development, S.N.C. Ligands that modulate lxr-type receptors
JP4761756B2 (ja) * 2003-10-31 2011-08-31 大塚製薬株式会社 2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物
US7601844B2 (en) * 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
AR060404A1 (es) * 2006-04-11 2008-06-11 Novartis Ag Compuestos organicos utiles como inhibidores de dipeptidil-peptidasa iv
HUP0600808A3 (en) * 2006-10-27 2008-09-29 Richter Gedeon Nyrt New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
US20100298299A1 (en) * 2007-10-27 2010-11-25 Istvan Vago non-peptide derivatives as bradykinin b1 antagonists
AU2009225441B2 (en) * 2008-03-20 2012-12-13 Forest Laboratories Holdings Limited Novel piperidine derivatives as inhibitors of stearoyl-CoA desaturase
WO2010065799A2 (en) * 2008-12-04 2010-06-10 Palatin Technologies, Inc. Amine substituted piperidine melanocortin receptor-specific compounds
WO2010091164A1 (en) * 2009-02-06 2010-08-12 Exelixis, Inc. Inhibitors of glucosylceramide synthase
DE102009033392A1 (de) * 2009-07-16 2011-01-20 Merck Patent Gmbh Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
CN102574822A (zh) * 2009-08-04 2012-07-11 阿米拉制药公司 作为溶血磷脂酸受体拮抗剂的化合物
US8497371B2 (en) * 2009-10-26 2013-07-30 University Of Memphis Research Foundation Pipemidic acid derivative autotaxin inhibitors
US8518945B2 (en) * 2010-03-22 2013-08-27 Hoffmann-La Roche Inc. Pyrrolopyrazine kinase inhibitors
JP2011219368A (ja) * 2010-04-02 2011-11-04 Daiichi Sankyo Co Ltd N−サリチルアミノ酸誘導体
WO2012024620A2 (en) * 2010-08-20 2012-02-23 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
EP2714680B1 (en) * 2011-05-27 2015-11-25 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
WO2013061297A1 (en) * 2011-10-28 2013-05-02 Pfizer Limited Pyridazine Derivatives Useful in Therapy
ES2623528T3 (es) * 2012-09-21 2017-07-11 Sanofi Derivados de amida de ácido benzoimidazolcarboxílico para tratar enfermedades metabólicas o cardiovasculares

Similar Documents

Publication Publication Date Title
JP2017526614A5 (enExample)
JP2016500661A5 (enExample)
JP2018519323A5 (enExample)
JP2017525757A5 (enExample)
JP2019537605A5 (enExample)
JP2020521767A5 (enExample)
RU2016115803A (ru) Замещенные никотинимидные ингибиторы втк, их получение и применение в терапии раковых, воспалительных и аутоиммунных заболеваний
JP2016512515A5 (enExample)
JP2016535772A5 (enExample)
JP2017511794A5 (enExample)
RU2009119290A (ru) Производные гидантоина, используемые в качестве ингибиторов ммр
JP2015501833A5 (enExample)
JP2010539110A5 (enExample)
JP2010540525A5 (enExample)
JP2019536785A5 (enExample)
JP2014506599A5 (enExample)
JP2009515988A5 (enExample)
JP2011502956A5 (enExample)
RU2014122033A (ru) Соединения с нематоцидной активностью
JP2017500334A5 (enExample)
JP2016525136A5 (enExample)
JP2016532673A5 (enExample)
JP2009523812A5 (enExample)
JP2019513745A5 (enExample)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1